Sir Harpal Kumar
Sir Harpal Kumar is the President of Biopharma at Grail, where he advocates for innovative cancer detection technologies. He recently spoke about the promising results from the Galleri blood test, which could enhance early detection of aggressive cancers, potentially transforming cancer screening practices and treatment approaches.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Sir Harpal Kumar expressed confidence in the compelling results of the cancer detection test.
9